Medicine: Three sprays, never again Corona?
Reading time: 2 min.
|
- Scientists at Saarland University show in a study that a nasal spray containing azelastine reduces the risk of coronavirus infection by two-thirds.
- In the study involving 450 participants, 2.2 percent of the azelastine group became infected with Sars-CoV-2, compared to 6.7 percent in the control group.
- The over-the-counter nasal spray is intended to complement, but not replace, existing protective measures such as vaccinations, especially for risk groups during periods of high incidence.
This text was created with the assistance of generative artificial intelligence. Read more about our approach to AI.
At the start of the cold season, scientists are reporting an easy-to-use nasal spray against SARS-CoV-2 and other pathogens. However, the drug does not replace standard protective measures.
It would be a great idea for the next infection season: Simply spray a spray into the nose, and the approaching viruses and bacteria would no longer stand a chance. Whether wedged between sniffling people on buses and trains or during the world's largest exchange of aerosol particles, the Oktoberfest, protection against infection would remain stable. At first glance, this vision could finally become reality thanks to the work of doctors and scientists at Saarland University. The researchers from Saarbrücken have finally shown in a clinical study that an anti-allergic nasal spray containing the active ingredient azelastine reduces the risk of coronavirus infection by two-thirds.
Read more about the topic
süeddeutsche
